Meloxicam Ratiopharm

Meloxicam, the active ingredient in Meloxicam Ratiopharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adults.

GNH USA supplies Meloxicam Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation by inhibiting COX‑2, and it is indicated for the following conditions:

- Osteoarthritis: reduces joint pain and swelling. - Rheumatoid arthritis: alleviates inflammatory joint symptoms. - Ankylosing spondylitis: improves spinal pain and stiffness. - Acute pain: provides short‑term relief of moderate to severe pain.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Nausea. - Diarrhea. - Headache. - Dizziness. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic enzyme elevation or liver injury. - Renal impairment or failure. - Cardiovascular events including myocardial infarction or stroke. - Anaphylaxis or severe hypersensitivity reactions.

When prescribing meloxicam, clinicians should consider several safety measures:

- Renal function assessment: evaluate baseline creatinine and monitor periodically. - Hepatic monitoring: check liver enzymes before and during therapy. - Cardiovascular risk: use cautiously in patients with known heart disease. - Elderly patients: start at the lowest effective dose and monitor closely. - Hypersensitivity: avoid in individuals with known NSAID allergy. - Store at ambient temperature: keep in the original pack, protect from moisture.

Meloxicam can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - SSRIs or SNRIs: heightened bleeding potential. - ACE inhibitors: possible reduction in renal function. - Lithium: increased lithium levels.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance. - Corticosteroids: increased ulcer risk. - Methotrexate: reduced clearance leading to toxicity. - Cyclosporine: heightened nephrotoxicity. - Antihypertensives: possible attenuation of blood‑pressure‑lowering effect.